Nektar Therapeutics NKTR Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nektar Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nektar Therapeutics's prepaid & other current?
- Nektar Therapeutics (NKTR) reported prepaid & other current of $20.44M in Q1 2026.
- How has Nektar Therapeutics's prepaid & other current changed year-over-year?
- Nektar Therapeutics's prepaid & other current increased by 81.2% year-over-year, from $11.28M to $20.44M.
- What is the long-term trend for Nektar Therapeutics's prepaid & other current?
- Over 5 years (2020 to 2025), Nektar Therapeutics's prepaid & other current has grown at a -1.3% compound annual growth rate (CAGR), from $21.93M to $20.51M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.